Cargando…

Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe

BACKGROUND: Hereditary angioedema (HAE) is a rare, debilitating, and potentially life-threatening disease characterized by recurrent edema attacks. Important advances in HAE treatment have been made, including the development of new therapies for treating or preventing attacks. Nevertheless, the dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zanichelli, Andrea, Magerl, Markus, Longhurst, Hilary, Fabien, Vincent, Maurer, Marcus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751114/ https://www.ncbi.nlm.nih.gov/pubmed/23937903 http://dx.doi.org/10.1186/1710-1492-9-29

Ejemplares similares

Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey
por: Zanichelli, Andrea, et al.
Publicado: (2018)

Hereditary Angioedema Attacks Resolve Faster and Are Shorter after Early Icatibant Treatment
por: Maurer, Marcus, et al.
Publicado: (2013)

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series
por: Maurer, Marcus, et al.
Publicado: (2022)

The Icatibant Outcome Survey: treatment of laryngeal angioedema attacks
por: Longhurst, Hilary J., et al.
Publicado: (2016)

Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey
por: Longhurst, H. J., et al.
Publicado: (2017)

Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study
por: Caballero, Teresa, et al.
Publicado: (2018)

Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey
por: Aberer, Werner, et al.
Publicado: (2017)

WAO Guideline for the Management of Hereditary Angioedema
por: Craig, Timothy, et al.
Publicado: (2012)

Editorial: C1 inhibitor deficiency and angioedema
por: Farkas, Henriette, et al.
Publicado: (2022)

The Global Registry for Hereditary Angioedema due to C1-Inhibitor Deficiency
por: Zanichelli, Andrea, et al.
Publicado: (2021)

Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey
por: Bygum, Anette, et al.
Publicado: (2019)

Impact of lanadelumab on health‐related quality of life in patients with hereditary angioedema in the HELP study
por: Lumry, William R., et al.
Publicado: (2020)

International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency
por: Farkas, H., et al.
Publicado: (2016)

Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study
por: Banerji, Aleena, et al.
Publicado: (2021)

Secreted Phospholipases A(2) in Hereditary Angioedema With C1-Inhibitor Deficiency
por: Loffredo, Stefania, et al.
Publicado: (2018)

Management of acute attacks of hereditary angioedema: potential role of icatibant
por: Longhurst, Hilary J
Publicado: (2010)

Treatment of hereditary angioedema—single or multiple pathways to the rescue
por: Valerieva, Anna, et al.
Publicado: (2022)

Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk
por: Reshef, A, et al.
Publicado: (2015)

Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)
por: Parsopoulou, Faidra, et al.
Publicado: (2022)

Optimum Use of Acute Treatments for Hereditary Angioedema: Evidence-Based Expert Consensus
por: Longhurst, Hilary
Publicado: (2018)

Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies
por: Busse, Paula J., et al.
Publicado: (2018)

Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks
por: Riedl, Marc A., et al.
Publicado: (2020)

A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy
por: Zanichelli, Andrea, et al.
Publicado: (2015)

Hereditary angioedema due to C1 inhibitor deficiency in Belarus: epidemiology, access to diagnosis and seven novel mutations in SERPING1 gene
por: Guryanova, Irina, et al.
Publicado: (2021)

A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy
por: Zanichelli, Andrea, et al.
Publicado: (2015)

Mitigating Disparity in Health-care Resources Between Countries for Management of Hereditary Angioedema
por: Jindal, Ankur Kumar, et al.
Publicado: (2021)

Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies
por: Bonner, Nicola, et al.
Publicado: (2015)

A Review of Randomized Controlled Trials of Hereditary Angioedema Long-Term Prophylaxis with C1 Inhibitor Replacement Therapy: Alleviation of Disease Symptoms Is Achievable
por: Longhurst, Hilary J, et al.
Publicado: (2023)

Patient‐physician interactions in hereditary angioedema—Key learnings from the coronavirus disease 2019 pandemic
por: Maurer, Marcus, et al.
Publicado: (2023)

Clinical Utility Gene Card for hereditary angioedema with normal C1 inhibitor (HAEnC1)
por: Stieber, Christiane, et al.
Publicado: (2017)

Pediatric hereditary angioedema due to C1-inhibitor deficiency
por: Farkas, Henriette
Publicado: (2010)

Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe
por: Aygören-Pürsün, Emel, et al.
Publicado: (2014)

Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United Kingdom
por: Longhurst, Hilary J., et al.
Publicado: (2018)

C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option
por: Longhurst, H J, et al.
Publicado: (2007)

588 Delayed Diagnosis of Hereditary Angioedema. A Case Report
por: González-Díaz, Sandra, et al.
Publicado: (2012)

The diagnosis of hereditary angioedema with C1 inhibitor deficiency: a survey of Canadian physicians and laboratories
por: Charest-Morin, Xavier, et al.
Publicado: (2018)

Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor
por: Bork, Konrad
Publicado: (2010)

Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
por: Agostoni, Angelo, et al.
Publicado: (2004)

Hereditary angioedema without deficiency of C1 inhibitor: response to therapy
por: Pimenta, Fabiane Milena Castro Araújo, et al.
Publicado: (2015)

Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency
por: Rubinstein, Eitan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t51lt39agibtouaam4d6ehmn7u